Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212

Sofia, Bulgaria, February 27, 2024 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that in pursuance of a decision of the General meeting of Holders of Warrants (GMHW) held on January 26, 2024 and decision of the Board of Directors of SOPHARMA AD from a meeting held on January 26, 2024 and based on art. 195 and art. 196 of the Commercial Law (CL), art. 113, para. 2, item 2 of Law on public offering of securities (LPOS) and art.

Русский

Sales revenues for January 2024

Sofia, Bulgaria, February 19, 2024 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for January 2024 the Company recorded an increase in sales of 32% compared to the same month of the previous year, incl. 16% increase in domestic sales and 44% increase in export sales.

Русский

Страницы